Similar articles

• Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.

  Giebel LB, Spritz RA. Giebel LB, et al. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8696-9. doi: 10.1073/pnas.88.19.8696. Proc Natl Acad Sci U S A. 1991. PMID: 1717985 Free PMC article.
• Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism.

  Spritz RA, Holmes SA, Ramesar R, Greenberg J, Curtis D, Beighton P. Spritz RA, et al. Am J Hum Genet. 1992 Nov;51(5):1058-65. Am J Hum Genet. 1992. PMID: 1384325 Free PMC article.
• Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism.

  Spritz RA, Giebel LB, Holmes SA. Spritz RA, et al. Am J Hum Genet. 1992 Feb;50(2):261-9. Am J Hum Genet. 1992. PMID: 1370874 Free PMC article.
• Molecular basis of human piebaldism.

  Spritz RA. Spritz RA. J Invest Dermatol. 1994 Nov;103(5 Suppl):137S-140S. doi: 10.1111/1523-1747.ep12399455. J Invest Dermatol. 1994. PMID: 7525736 Review.
• The cell surface receptor encoded by the proto-oncogene KIT and its ligand.

  McCulloch EA, Minden MD. McCulloch EA, et al. Cancer Treat Res. 1993;64:45-77. doi: 10.1007/978-1-4615-3086-2_4. Cancer Treat Res. 1993. PMID: 7680877 Review. No abstract available.